chartexchange

Perrigo: 3 Key Takeaways for Long-Term Investors

The Motley Fool | Nov 6, 2026 9:11 PM EST

On its third-quarter 2026 earnings call, held on Nov. 4, 2026, Perrigo (NYSE:PRGO) announced an agreement to sell its infant formula business. The divestment removes a cash-draining operation and frees up capital for higher-margin health products. Three takeaways from management stand out. Management is streamlining its portfolio to focus on high-return self-care products, which are non-prescription health goods. The sale reduces capital expenditures, or capex, and improves the operating margin profile. Online shopping is outpacing growth in physical retail, and Perrigo holds a higher market share in e-commerce than in offline stores. Management is doubling down on digital distribution to capture shifting consumer habits. Continue reading

Read original article